PGNY Q2 2025 Earnings — Progyny, Inc. Revenue & Financial Results | Market Cap Arena

PGNYProgyny, Inc.

$1B

Q2 2025 Earnings

Healthcare Medical - Healthcare Information Services

Income Statement

Revenue

$333M+9.5% YoY

Gross Profit

$79M23.7% margin

Operating Income

$24M7.3% margin

Net Income

$17M5.1% margin

EPS (Diluted)

$0.19

QoQ Revenue Growth

+2.7%

Cash Flow

Operating Cash Flow

$56M

Free Cash Flow

$50M

Stock-Based Comp.

$32M

Balance Sheet

Total Assets

$761M

Total Liabilities

$246M

Stockholders' Equity

$515M

Cash & Equivalents

$133M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$333M	$304M	+9.5%
Gross Profit	$79M	$68M	+15.7%
Operating Income	$24M	$21M	+17.7%
Net Income	$17M	$16M	+3.8%

Revenue Segments

Fertility benefit services revenue

$214M64%

Pharmacy benefit services revenue

$119M36%